Literature DB >> 2170370

Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase.

M Hatzoglou1, W Lamers, F Bosch, A Wynshaw-Boris, D W Clapp, R W Hanson.   

Abstract

Two methods are described for directing the expression of genes to the livers of animals using retroviral vectors containing the predominantly liver-specific promoter from the gene for phosphoenolpyruvate carboxykinase (PEPCK)-linked to the structural gene for either amino 3'-glycosyl phosphotransferase (neo) or bovine growth hormone (bGH). Replication-incompetent retrovirus was used to infect the livers of fetal rats by intraperitoneal injection of animals in utero or to infect adult rats by direct injection into the portal vein after partial hepatectomy. The proviruses were integrated into the hepatic DNA, and the chimeric genes were expressed from the PEPCK promoter for as long as 8 months after infection. The expression of the PEPCK-bGH gene was regulated by diet and hormones in a manner similar to the regulation of the endogenous PEPCK gene in the liver. The potential of this method for targeting genes to the liver is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170370

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Retroviral-mediated gene transfer into hepatocytes in vivo.

Authors:  N Ferry; O Duplessis; D Houssin; O Danos; J M Heard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo.

Authors:  A Lieber; M J Vrancken Peeters; L Meuse; N Fausto; J Perkins; M A Kay
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 3.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

4.  Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected].

Authors:  C J Petropoulos; W Payne; D W Salter; S H Hughes
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.

Authors:  S D Rettinger; S C Kennedy; X Wu; R L Saylors; D G Hafenrichter; M W Flye; K P Ponder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Hormonal regulation of the gene for the type C ecotropic retrovirus receptor in rat liver cells.

Authors:  J Y Wu; D Robinson; H J Kung; M Hatzoglou
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting.

Authors:  W Walther; U Stein
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

8.  Enhanced gene expression of the murine ecotropic retroviral receptor and its human homolog in proliferating cells.

Authors:  T Yoshimoto; E Yoshimoto; D Meruelo
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Transfer of a constitutive viral promoter-cystic fibrosis transmembrane conductance regulator cDNA to human epithelial cells conveys resistance to down-regulation of cAMP-regulated Cl- secretion in the presence of inflammatory stimuli.

Authors:  N Kobayashi; E R Rosenthal; K Yoshimura; R G Crystal
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

Review 10.  Current advances in retroviral gene therapy.

Authors:  Youngsuk Yi; Moon Jong Noh; Kwan Hee Lee
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.